Skip to main content

Table 3 Effect of Chrysin and sildenafil against ZnO-NPs induced hepatic enzymes elevation

From: The alleviative efficacy of sildenafil and chrysin against zinc oxide nanoparticles-provoked hepatic and blood toxicity: role of MyD88/NF-κB1/TNF-α pathway

N = 6

Control

ZnO-NPs

Sildenafil

Chrysin

Prophylaxis Chrysin

Chrysin-treated

Sildenafil-treated

Combined-treated

ALT (U/L)

23.10 ± 0.378

A

68.84 ± 0.560

B

23.44 ± 0.324

A

23.19 ± 0.377

A

48.92 ± 0.660

C

49.13 ± 0.739

C

43.95 ± 0.530

D

35.30 ± 0.672

E

AST (U/L)

37.02 ± 0.492

A

72.46 ± 0.781

B

37.03 ± 0.713

A

37.17 ± 0.47

A

61.25 ± 0.489

C

61.40 ± 0.819

C

54.71 ± 1.033

D

45.98 ± 0.539

E

ALP (U/L)

45.00 ± 0.9129 A

88.82 ± 0.3765

B

46.05 ± 0.8305

A

46.79 ± 1.048

A

77.47 ± 0.9317

C

72.32 ± 1.159

D

63.59 ± 0.8434

E

52.21 ± 0.7403

F

  1. ALT alanine transferase, AST aspartate transaminase, ALP alkaline phosphatase
  2. Values represent Mean ± SEM. Within the same row, values without common subscript capital letters are significantly different (p < 0.0001)